Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Kalliopi Zafeiropoulou"'
Autor:
Kalliopi Zafeiropoulou, Georgios Kalampounias, Spyridon Alexis, Daniil Anastasopoulos, Argiris Symeonidis, Panagiotis Katsoris
Publikováno v:
PLoS ONE, Vol 19, Iss 2, p e0289904 (2024)
Proteasome inhibitors such as Bortezomib represent an established type of targeted treatment for several types of hematological malignancies, including multiple myeloma, Waldenstrom's macroglobulinemia, and mantle cell lymphoma, based on the cancer c
Externí odkaz:
https://doaj.org/article/3390dfd76d194a898475af7f4ba199db
Autor:
Ioannis Mitroulis, Vasileios Papadopoulos, Eleftheria Lamprianidou, Peter Mirtschink, Konstantinos Liapis, Kalliopi Zafeiropoulou, Alexandra Kourakli, Theodoros Moysiadis, Menelaos Papoutselis, George Vrachiolias, Argiris Symeonidis, Ioannis Kotsianidis
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-5 (2023)
Externí odkaz:
https://doaj.org/article/78f000cac3734f8eb421a796713b774f
Autor:
Kalliopi Zafeiropoulou, Theodora Bita, Apostolos Polykratis, Stella Karabina, John Vlachojannis, Panagiotis Katsoris
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e30975 (2012)
Chronic kidney disease is linked to systemic inflammation and to an increased risk of ischemic heart disease and atherosclerosis. Endothelial dysfunction associates with hypertension and vascular disease in the presence of chronic kidney disease but
Externí odkaz:
https://doaj.org/article/b46ce3d150eb464d8670c0afe3d13264
Autor:
Vassiliki Mpakou, Aris Spathis, Anthi Bouchla, Zoi Tsakiraki, Frieda Kontsioti, Sotirios Papageorgiou, Efthymia Bazani, Konstantinos Gkontopoulos, Thomas Thomopoulos, Irene Glezou, Athanasios Galanopoulos, Argiris Symeonidis, Panagiotis T. Diamantopoulos, Nora‐Athina Viniou, Christina‐Nefeli Kontandreopoulou, Kalliopi Zafeiropoulou, Ioannis Kotsianidis, Eleftheria Lamprianidou, Periklis Foukas, Aristoteles Mpamias, Vasiliki Pappa
Publikováno v:
Hematological Oncology. 39
Autor:
null Vassiliki Mpakou, null Aris Spathis, null Anthi Bouchla, null Zoi Tsakiraki, null Frieda Kontsioti, null Sotirios Papageorgiou, null Efthymia Bazani, null Konstantinos Gkontopoulos, null Thomas Thomopoulos, null Irene Glezou, null Athanasios Galanopoulos, null Argiris Symeonidis, null Panagiotis T. Diamantopoulos, null Nora‐Athina Viniou, null Christina‐Nefeli Kontandreopoulou, null Kalliopi Zafeiropoulou, null Ioannis Kotsianidis, null Eleftheria Lamprianidou, null Periklis Foukas, null Aristoteles Mpamias, null Vasiliki Pappa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::736b52559d7fc080a714c89d7f3f4675
https://doi.org/10.1002/hon.2834/v2/response1
https://doi.org/10.1002/hon.2834/v2/response1
Autor:
Irene Glezou, Nora-Athina Viniou, Eleftheria Lamprianidou, Periklis G. Foukas, Konstantinos Gkontopoulos, Panagiotis T. Diamantopoulos, Efthymia Bazani, Frieda Kontsioti, Thomas P. Thomopoulos, Christina-Nefeli Kontandreopoulou, Vassiliki E. Mpakou, Vasiliki Pappa, Ioannis Kotsianidis, Zoi Tsakiraki, Sotirios G. Papageorgiou, Aristoteles Mpamias, Argiris Symeonidis, Anthi Bouchla, Athanasios Galanopoulos, Aris Spathis, Kalliopi Zafeiropoulou
Publikováno v:
Hematological oncologyREFERENCES. 39(2)
5-azacytidine (5-AZA) is considered the standard of care for patients with high-risk myelodysplastic syndromes (MDS) and patients with acute myeloid leukemia (AML) not candidate for intensive chemotherapy. However, even after an initial favorable res
Autor:
Vassiliki Pappa, Zoi Tsakiraki, Aris Spathis, Frieda Kontsioti, Athanasios Galanopoulos, Periklis G. Foukas, Vassiliki E. Mpakou, Efthimia Mpazani, Nora-Athina Viniou, Argiris Symeonidis, Ioannis Kotsianidis, Anthi Bouhla, Kalliopi Zafeiropoulou, Georgia Stavroulaki, Sotirios G. Papageorgiou, Irene Glezou, Konstantinos Gkodopoulos
Publikováno v:
Blood. 134:5403-5403
Introduction: Azacitidine (AZA) is a hypomethylating agent that at low doses acts by inhibiting DNA methyltranferase activity. AZA is approved and widely used for the treatment of MDS patients and patients with AML not candidate for intensive chemoth
Autor:
A. Galanopoulos, Petros Karakitsos, Irene Glezou, Kalliopi Zafeiropoulou, Georgia Stavroulaki, Ioannis Kotsianidis, S. Papageorgiou, K. Gontopoulos, Frieda Kontsioti, Argiris Symeonidis, Vassiliki Pappa, George Dimitriadis, Aris Spathis, Diamantina Vasilatou, Vassiliki E. Mpakou, Nora Viniou, Efthymia Bazani, Anthi Bouhla, E. Kontandreopoulou
Publikováno v:
Publons
Autor:
Stella Karabina, Theodora Bita, Panagiotis Katsoris, Kalliopi Zafeiropoulou, John G. Vlachojannis, Apostolos Polykratis
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 2, p e30975 (2012)
PLoS ONE, Vol 7, Iss 2, p e30975 (2012)
Chronic kidney disease is linked to systemic inflammation and to an increased risk of ischemic heart disease and atherosclerosis. Endothelial dysfunction associates with hypertension and vascular disease in the presence of chronic kidney disease but
Autor:
Theodoros P. Vassilakopoulos, Zoi Topouzoglou, Apostolos I. Hatzitolios, Aleka Kourakli, Eleni Bouronikou, Panagiotis T. Diamantopoulos, Eleftheria Hatzimichael, Anastasia Sioni, Stamatina Kalyva, Achilles Anagnostopoulos, Vassiliki Pappa, Helen A. Papadaki, Ioannis Kotsianidis, Evangelos Briasoulis, Maria Dimou, Paraskevi Roussou, Anna Vardi, Dimitris Tsokanas, Christos K. Kontos, Aikaterini Megalakaki, Georgia Kaiafa, Nora-Athina Viniou, Anastasia Pouli, Stamatis Karakatsanis, Menelaos Papoutselis, Nikolaos Anagnostopoulos, Flora N. Kontopidou, Maria Spiliotopoulou, Argiris Symeonidis, George Vassilopoulos, Kalliopi Zafeiropoulou, Athanasios Galanopoulos, Nikolaos Charchalakis, Panayiotis Panayiotidis, Vasilios Lazaris
Publikováno v:
Publons
Introduction - Aims: Several prognostic scoring systems have been developed for patients with myelodysplastic syndromes (MDS), including the International Prognostic System (IPSS), the WHO Prognostic Scoring System (WPSS) and the Revised IPSS (IPSS-R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60e1140bb0d7ed5af36adf828aa01619
https://publons.com/publon/28569274/
https://publons.com/publon/28569274/